Literature DB >> 17712607

Active bovine selenophosphate synthetase 2, not having selenocysteine.

Kenji Furumiya1, Kazuo Kanaya, Kazutaka Tanabe, Yuta Tanaka, Takaharu Mizutani.   

Abstract

During the course of studying selenocysteine (Sec) synthesis mechanisms in mammals, we prepared selenophosphate synthetase (SPS) from bovine liver by 4-step chromatography. In the last step of chromatography of hydroxyapatite, we found a protein band of molecular mass 33 kDa on SDS-PAGE, consistent with the pattern of SPS activity that was indirectly manifested by [(75)Se]Sec production activity; however, we could not detect significant Se content in this active fraction. We also found a clear band of 33 kDa by Western blotting with antibody against a common peptide (387-401) in SPS2. We detected selenophosphate as the product of this active enzyme in the reaction mixture, composed of ATP, [(75)Se]H(2)Se and SPS. Chemically synthesized selenophosphate plays a role in Sec synthesis, not the addition of this enzyme. These results support that the product of SPS2 is selenophosphate itself. During this investigation, the probable sequence of bovine SPS2 not having Sec was reported in the blast information and the molecular mass was near with the protein in this report. Thus, bovine active SPS2 of molecular mass 33 kDa does not contain Sec.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17712607     DOI: 10.1007/s11033-007-9120-4

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  30 in total

1.  Selenophosphate as a substrate for mammalian selenocysteine synthase, its stability and toxicity.

Authors:  T Mizutani; K Kanaya; K Tanabe
Journal:  Biofactors       Date:  1999       Impact factor: 6.113

2.  Protection of bovine seryl-transfer ribonucleic acid (seryl-tRNA) synthetase from chemical modification by its substrates, and some kinetic parameters.

Authors:  Y Tachibana; T Mizutani
Journal:  Chem Pharm Bull (Tokyo)       Date:  1988-10       Impact factor: 1.645

3.  The primary structure of valine-I transfer ribonucleic acid from Torulopsis utilis. I. Complete digestion with pancreatic ribonuclease and ribonuclease T1.

Authors:  S Takemura; T Mizutani; M Miyazaki
Journal:  J Biochem       Date:  1968-12       Impact factor: 3.387

4.  Selenophosphate.

Authors:  R S Glass; T C Stadtman
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

5.  Early embryonic lethality caused by targeted disruption of the mouse selenocysteine tRNA gene (Trsp).

Authors:  M R Bösl; K Takaku; M Oshima; S Nishimura; M M Taketo
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

6.  The dual identities of mammalian tRNA(Sec) for SerRS and selenocysteine synthase.

Authors:  T Mizutani; K Kanaya; S Ikeda; T Fujiwara; K Yamada; T Totsuka
Journal:  Mol Biol Rep       Date:  1998-11       Impact factor: 2.316

7.  Effects of monovalent cations and divalent metal ions on Escherichia coli selenophosphate synthetase.

Authors:  I Y Kim; T C Stadtman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

8.  The long extra arms of human tRNA((Ser)Sec) and tRNA(Ser) function as major identify elements for serylation in an orientation-dependent, but not sequence-specific manner.

Authors:  X Q Wu; H J Gross
Journal:  Nucleic Acids Res       Date:  1993-12-11       Impact factor: 16.971

9.  Selenophosphate synthetase. Enzyme properties and catalytic reaction.

Authors:  Z Veres; I Y Kim; T D Scholz; T C Stadtman
Journal:  J Biol Chem       Date:  1994-04-08       Impact factor: 5.157

10.  Recognition of UGA as a selenocysteine codon in type I deiodinase requires sequences in the 3' untranslated region.

Authors:  M J Berry; L Banu; Y Y Chen; S J Mandel; J D Kieffer; J W Harney; P R Larsen
Journal:  Nature       Date:  1991-09-19       Impact factor: 49.962

View more
  1 in total

Review 1.  The human selenoproteome: recent insights into functions and regulation.

Authors:  M A Reeves; P R Hoffmann
Journal:  Cell Mol Life Sci       Date:  2009-04-28       Impact factor: 9.261

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.